Jefferies Starts Urovant Ltd. (UROV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts UROV Hot Sheet
Price: $16.24 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Join SI Premium – FREE
Jefferies analyst Biren Amin initiates coverage on Urovant Ltd. (NASDAQ: UROV) with a Buy rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Urovant Ltd. click here. For more ratings news on Urovant Ltd. click here.
Shares of Urovant Ltd. closed at $12.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts AbCellera Biologics (ABCL) at Buy
- UBS Starts DO & CO AG (DOC:AV) at Buy
- CLSA Starts Time Interconnect Technology (1729:HK) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
